1-2 of 2
Olaf Stuve, MD
Close
Sort by
Journal Articles

Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)

Richard A. Nash, MD, George J. Hutton, MD, Michael K Racke, MD, Uday R. Popat, M.D., Steven M. Devine, MD, George E. Georges, MD, Linda M. Griffith, MD, PhD, Paolo A Muraro, MD, Harry Openshaw, MD, Peter H. Sayre, MD, PhD, Olaf Stuve, MD, Douglas L Arnold, MD, Meagan Spychala, Noha Lim, PhD, Sachin Malhotra, PhD, Deborah Phippard, PhD, Annette Wundes, MD, George H Kraft, MD, James D Bowen, MD
Journal: Blood
Blood (2012) 120 (21): 962.
https://doi.org/10.1182/blood.V120.21.962.962
Published: 2012
Journal Articles

Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: Early Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)

Richard A. Nash, MD, George J Hutton, MD, Michael K Racke, MD, Uday R Popat, MD, Steven M. Devine, MD, Linda M. Griffith, MD, PhD, Paolo A Muraro, MD, Harry Openshaw, MD, Peter H. Sayre, MD, PhD, Olaf Stuve, MD, Douglas L Arnold, MD, Lisa Wruck, PhD, Annette Wundes, MD, George H Kraft, MD, James D Bowen, MD
Journal: Blood
Blood (2011) 118 (21): 3075.
https://doi.org/10.1182/blood.V118.21.3075.3075
Published: 2011